CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Vaxiion Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Vaxil Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Veana Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Vector Y Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Vedanta Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Vega Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Veganic SKN — — —
60
42% 		7/20/2026 View Intelligence
Velicept Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Veloce Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Velocity Pharma — — —
60
40% 		7/20/2026 View Intelligence
Veloxis Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Venatorx Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Venn Biosciences 1 trials — —
60
36% 		7/17/2026 View Intelligence
Vensica Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Venterpharma — — —
60
36% 		7/17/2026 View Intelligence
Ventrus Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Ventus Therapeutics Us — — —
60
36% 		7/17/2026 View Intelligence
Ventyx Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Veongen Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Vera Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Veralox Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Verb Products — — —
60
40% 		7/20/2026 View Intelligence
Vericel — — —
60
40% 		7/20/2026 View Intelligence
Veridian Healthcare — — —
60
42% 		7/20/2026 View Intelligence
Verismo Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Verity Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Verona Pharma — — —
60
36% 		7/17/2026 View Intelligence
Verona Pharma A Subsidiary Of Merck & (rahway New Jersey Usa — — —
60
36% 		7/17/2026 View Intelligence
Verrica Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Vertero Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Vertex Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Vertex Pharmaceuticals 8 trials — —
75
45% 		7/17/2026 View Intelligence
Verve Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Vesale Pharmaceutica — — —
60
36% 		7/17/2026 View Intelligence
Vespyr Brands — — —
60
42% 		7/20/2026 View Intelligence
Vetstem Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Vgx Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Vi-Jon — — —
60
40% 		7/20/2026 View Intelligence
Viable Biosciences 1 trials — —
60
36% 		7/17/2026 View Intelligence
Viatris Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Viatris Pharmaceuticals Japan — — —
60
36% 		7/17/2026 View Intelligence
Viatris Specialty — — —
60
42% 		7/20/2026 View Intelligence
Vicept Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Vico Therapeutics B V — — —
60
36% 		7/17/2026 View Intelligence
Vicore Pharma — — —
60
36% 		7/17/2026 View Intelligence
Vicuron Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Vicus Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Vidac Pharma — — —
60
36% 		7/17/2026 View Intelligence
Vidara Therapeutics Research — — —
60
36% 		7/17/2026 View Intelligence
Vidya Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Showing 6251 - 6300 of 6,643 companies